Live from the NIH registry
Studies recruiting near Surprise right now
Top 25 of 998 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Cancer Treatment Centers of America-Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
Mayo Clinic, Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Kumquat Biosciences Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
City of Hope - Phoenix ( Site 0202) — Goodyear, Arizona (17.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
Medical Dermatology Specialists Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Incyte Corporation
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Associated Retina Consultants, Ltd. — Phoenix, Arizona (27.1 mi)
· Sponsor: Boehringer Ingelheim
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low Back Pain
N/A
Interventional 2,529 participants sought
Phoenix VA Health Care System, Phoenix, AZ — Phoenix, Arizona (27.1 mi)
· Sponsor: VA Office of Research and Development
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (27.1 mi)
· Sponsor: Rejoni Inc.
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Digestive Health, Quality of Life
N/A
Interventional 114 participants sought
ASU Health Futures Center — Phoenix, Arizona (27.1 mi)
· Sponsor: Arizona State University
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona (11.9 mi)
· Sponsor: Annovis Bio Inc.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
Mayo Clinic Arizona — Phoenix, Arizona (27.1 mi)
· Sponsor: Cartography Biosciences
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: Medtronic Cardiovascular
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (27.1 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
CTCA at Western Regional Medical Center — Goodyear, Arizona (17.8 mi)
· Sponsor: SWOG Cancer Research Network
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Diabetes Mellitus, Chronic Kidney Diseases
N/A
Observational 500 participants sought
NIDDK-Phoenix Epidemiology and Clinical Research — Phoenix, Arizona (27.1 mi)
· Sponsor: University of New Mexico
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
Barrow Neurological Institute — Phoenix, Arizona (27.1 mi)
· Sponsor: AC Immune SA
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Goodyear, Arizona (17.8 mi)
· Sponsor: Pfizer
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Saguaro Dermatology — Phoenix, Arizona (27.1 mi)
· Sponsor: Incyte Corporation
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Phase 3
Interventional 468 participants sought
Clinical Trial Site — Goodyear, Arizona (17.8 mi)
· Sponsor: Syndax Pharmaceuticals
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Mayo Clinic - Arizona — Phoenix, Arizona (27.1 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Palo Verde Hematology Oncology — Glendale, Arizona (18.2 mi)
· Sponsor: Bristol-Myers Squibb
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
SunValley Arthritis Center, Ltd — Peoria, Arizona (14.2 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney Disease, Proteinuria
Phase 3
Interventional 100 participants sought
Phoenix Children's Hospital | Main - Transplant Department — Phoenix, Arizona (27.1 mi)
· Sponsor: Bayer